milrinone has been researched along with verapamil in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (29.41) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alousi, AA; Johnson, DC | 1 |
| Bentley, R; Canniff, PC; Farah, AE; Kaiser, LD | 1 |
| Evans, DB; Harris, AL; Lemp, BM; Silver, PJ | 1 |
| Blas, SD; Davis, FB; Davis, PJ; Dube, MP; Mylotte, KM; Warnick, PR | 1 |
| Riley, CM | 1 |
| Miao, L; Morgan, JP; Perreault, CL; Travers, KE | 1 |
| Aardal, S; Helle, KB; Lillestłl, IK | 1 |
| Onur, R; Yenisehirli, A | 1 |
| Bouchard, M; Dupré, N; Gariépy, JL; Verreault, S | 1 |
| Batzias, GC; Koutsoviti-Papadopoulou, M; Psarra, TA | 1 |
| Aggour, M; Moret, J; Pierot, L | 1 |
| de A Cavalcante, F; de Correia, AC; de Lira, DP; de O Santos, BV; Macêdo, CL; Martins, IR; Silva, BA; Vasconcelos, LH | 1 |
2 review(s) available for milrinone and verapamil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Vasospasm after aneurysmal subarachnoid hemorrhage: recent advances in endovascular management.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angioplasty, Balloon; Critical Care; Endovascular Procedures; Humans; Intensive Care Units; Milrinone; Nicardipine; Papaverine; Risk Factors; Subarachnoid Hemorrhage; Vasodilator Agents; Vasospasm, Intracranial; Verapamil | 2010 |
15 other study(ies) available for milrinone and verapamil
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Pharmacology of the bipyridines: amrinone and milrinone.
Topics: Acetylcholine; Aminopyridines; Amrinone; Animals; Calcium; Carbachol; Cardiotonic Agents; Cats; Cyclic AMP; Dibutyryl Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Female; Guinea Pigs; Heart; Hemodynamics; Ion Channels; Male; Milrinone; Myocardial Contraction; Norepinephrine; Potassium; Pyridones; Receptors, Muscarinic; Sodium; Stimulation, Chemical; Time Factors; Verapamil | 1986 |
Effect of milrinone (Corotrope) on the contractility of isolated dog ventricular muscle.
Topics: Animals; Calcium Channel Blockers; Cardiotonic Agents; Dogs; Dose-Response Relationship, Drug; Heart; In Vitro Techniques; Microelectrodes; Milrinone; Myocardial Contraction; Pyridones; Ruthenium Red; Verapamil | 1987 |
The vasorelaxant effects of milrinone and other vasodilators are attenuated by ouabain.
Topics: Animals; Aorta, Thoracic; Colforsin; Drug Interactions; Female; Guinea Pigs; Hydralazine; In Vitro Techniques; Isoproterenol; Isoquinolines; Isosorbide; Milrinone; Nitroprusside; Ouabain; Pyridones; Sodium-Potassium-Exchanging ATPase; Sulfonamides; Vasodilator Agents; Verapamil | 1988 |
Calcium channel blocker inhibition of the calmodulin-dependent effects of thyroid hormone and milrinone on rabbit myocardial membrane Ca2+-ATPase activity.
Topics: Animals; Calcium-Transporting ATPases; Calmodulin; In Vitro Techniques; Milrinone; Myocardium; Nifedipine; Pyridones; Rabbits; Sarcolemma; Sulfonamides; Thyroxine; Verapamil | 1988 |
Stability of milrinone and digoxin, furosemide, procainamide hydrochloride, propranolol hydrochloride, quinidine gluconate, or verapamil hydrochloride in 5% dextrose injection.
Topics: Digoxin; Drug Combinations; Drug Stability; Drug Storage; Furosemide; Glucose; Indicators and Reagents; Milrinone; Procainamide; Propranolol; Pyridones; Quinidine; Solutions; Temperature; Verapamil | 1988 |
Mechanisms of positive inotropic action of flosequinan, hydralazine, and milrinone on mammalian myocardium.
Topics: Aequorin; Animals; Calcium Channel Blockers; Cardiotonic Agents; Carrier Proteins; Enzyme Inhibitors; Ferrets; Heart; Hydralazine; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Ouabain; Procaine; Pyridones; Quinolines; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Stimulation, Chemical; Tetrodotoxin; Vasodilator Agents; Verapamil | 1997 |
Relaxing effects of cyclic GMP and cyclic AMP-enhancing agents on the long-lasting contraction to endothelin-1 in the porcine coronary artery.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Atrial Natriuretic Factor; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Colforsin; Coronary Vessels; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Isradipine; Milrinone; Muscle, Smooth, Vascular; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyrrolidinones; Rolipram; Swine; Vasoactive Intestinal Peptide; Vasoconstriction; Vasodilation; Verapamil; Vinca Alkaloids | 1998 |
Positive inotropic and negative chronotropic effects of proton pump inhibitors in isolated rat atrium.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Calcium Channel Blockers; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Heart Atria; Imidazoles; In Vitro Techniques; Lansoprazole; Male; Milrinone; Myocardial Contraction; Omeprazole; Ouabain; Phosphodiesterase Inhibitors; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Theophylline; Verapamil | 2005 |
Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome.
Topics: Anti-Inflammatory Agents; Brain; Calcium Channel Blockers; Cerebral Angiography; Female; Headache Disorders, Primary; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Middle Aged; Milrinone; Prednisone; Syndrome; Tomography, X-Ray Computed; Vasodilator Agents; Vasospasm, Intracranial; Verapamil | 2009 |
Milrinone and theophylline act as lower oesophageal sphincter relaxing agents: a comparative pharmacodynamic study in the rabbit.
Topics: Animals; Bronchodilator Agents; Esophageal Sphincter, Lower; Female; Male; Milrinone; Muscle Relaxation; Papaverine; Rabbits; Theophylline; Vasodilator Agents; Verapamil | 2009 |
Mechanisms underlying vasorelaxation induced in rat aorta by galetin 3,6-dimethyl ether, a flavonoid from Piptadenia stipulacea (Benth.) Ducke.
Topics: Aminophylline; Animals; Aorta; Calcium Chloride; Fabaceae; Flavonoids; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Phenylephrine; Piperazines; Potassium Channel Blockers; Purines; Rats, Wistar; Sildenafil Citrate; Sulfonamides; Vasodilation; Verapamil | 2014 |